Azithromycin with QT-prolonging drugs may elevate CV event risk – Healio

According to findings published in JAMA Network Open, the combination of azithromycin and QT-prolonging drugs was associated with a 40% increase in cardiac events compared with amoxicillin and QT-prolonging drugs.
However, in a large cohort, there was no difference between use of azithromycin and amoxicillin in risk for CV events, researchers reported.
Source: Adobe Stock.
“In this large cohort study including more than 4 million episodes of both azithromycin and amoxicillin use, we found no …

Click here to view the original article.